Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berry

Showing results (1271-1280 of 1,380) with videos related to

Pageof 138
Sort By:
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancyLaura C Matthews, Andrew A Berry, David J Morgan, et al.
Annals of Internal Medicine|November 19, 2009
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsJeanne S Mandelblatt, Kathleen A Cronin, Stephanie Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancerI Craig Henderson, Donald A Berry, George D Demetri, et al.
NPJ Precision Oncology|March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) studyApostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
The Journal of Infectious Diseases|August 17, 2019
Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive AdultsMatthew B Laurens, Andrea A Berry, Mark A Travassos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal CancerJim P Abraham, Daniel Magee, Chiara Cremolini, et al.
Molecular Genetics and Metabolism|November 21, 2015
Glutamine and hyperammonemic crises in patients with urea cycle disordersB Lee, G A Diaz, W Rhead, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without LapatinibLisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
American Journal of Human Genetics|May 11, 2015
Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3Jessica X Chong, Lindsay C Burrage, Anita E Beck, et al.
Pageof 138

Showing results (1271-1280 of 1,380) with videos related to

Sort By:
Pageof 138
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancyLaura C Matthews, Andrew A Berry, David J Morgan, et al.
Annals of Internal Medicine|November 19, 2009
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsJeanne S Mandelblatt, Kathleen A Cronin, Stephanie Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancerI Craig Henderson, Donald A Berry, George D Demetri, et al.
NPJ Precision Oncology|March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) studyApostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
The Journal of Infectious Diseases|August 17, 2019
Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive AdultsMatthew B Laurens, Andrea A Berry, Mark A Travassos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal CancerJim P Abraham, Daniel Magee, Chiara Cremolini, et al.
Molecular Genetics and Metabolism|November 21, 2015
Glutamine and hyperammonemic crises in patients with urea cycle disordersB Lee, G A Diaz, W Rhead, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without LapatinibLisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
American Journal of Human Genetics|May 11, 2015
Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3Jessica X Chong, Lindsay C Burrage, Anita E Beck, et al.
Pageof 138